For this reason, we aimed to assess (i) primarily the association between GDF-15 circulating levels and anorexia and (ii) secondarily with low muscle mass or body weight loss in cancer patients naïve to anti-cancer treatments. This evidence concerns the gene GDF15 and cancer.